Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 known ✓ | P29474 | 1/20 | 0.43 |
| ▸ | NOS1 known ✓ | P29475 | 1/20 | 0.43 |
| ▸ | NOS2 known ✓ | P35228 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | ARG1 | P05089 | 7/20 | 0.50 |
| ▸ | ARG2 | P78540 | 7/20 | 0.50 |
| ▸ | ODC1 | P11926 | 1/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GGT1 | P19440 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL58260 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL1133986 | 0.92 | MEN1 (0.62) | MEN1CYP1A2KMT2AALDH1A1THRB | |
| SCHEMBL22615903 | 0.82 | ALDH1A1 (0.54) | MEN1CYP1A2KMT2AALDH1A1THRB | |
| SCHEMBL5323365 | 0.81 | — | — | |
| SCHEMBL2458445 | 0.81 | — | — | |
| SCHEMBL1651824 | 0.81 | — | — | |
| SCHEMBL1650712 | 0.81 | — | — | |
| Acrylic Acid SCHEMBL29238214 | 0.80 | ALDH1A1 (0.52) | MEN1CYP1A2KMT2AALDH1A1THRB | |
| Hydrochloric Acid SCHEMBL31367633 | 0.80 | ALDH1A1 (0.52) | MEN1CYP1A2KMT2AALDH1A1THRB | |
| SCHEMBL28719235 | 0.80 | MEN1 (0.52) | MEN1CYP1A2KMT2AALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 773 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3566693-B1 | EYE DEVICE | EYED PHARMA (BE) | 2021-02-17 | — | — | EP | claimed |
| EP-3566693-A1 | EYE DEVICE | EyeD Pharma (BE) | 2019-11-13 | — | — | EP | claimed |
| EP-3068372-B1 | EYE DEVICE | EYED PHARMA (BE) | 2019-05-08 | — | — | EP | claimed |
| US-9999595-B2 | Eye device | EYED PHARMA (BE) | 2018-06-19 | — | — | US | claimed |
| EP-2305624-B1 | Self-degradable explosive device | MAXAMCORP HOLDING SL (ES) | 2017-09-27 | — | — | EP | claimed |
| US-20160287513-A1 | EYE DEVICE | EYED PHARMA (BE) | 2016-10-06 | — | — | US | claimed |
| EP-3068372-A1 | EYE DEVICE | EyeD Pharma (BE) | 2016-09-21 | — | — | EP | claimed |
| EP-2931278-A1 | ORAL FORM, COMPRISING IMMEDIATE-RELEASE COATED PARTICLES OF AT LEAST ONE ACTIVE COMPOUND THAT ARE GRINDING-RESISTANT | Flamel Ireland Limited (IE) | 2015-10-21 | — | — | EP | claimed |
| US-9149439-B2 | Multi-particulate, modified-release composition | SANDOZ AG (CH) | 2015-10-06 | — | — | US | claimed |
| WO-2015071427-A1 | EYE DEVICE | EYED PHARMA (BE) | 2015-05-21 | — | — | WO | claimed |
| US-20040208925-A1 | Dispersible alendronate microparticle formulation | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI | 2004-10-21 | — | — | US | claimed |
| US-20040115268-A1 | Systemic delivery of antiviral agents | CONTROL DELIVERY SYSTEMS, INC. | 2004-06-17 | — | — | US | claimed |
| WO-2004050066-A1 | MICROSPHERES AND RELATED PROCESSES AND PHARMACEUTICAL COMPOSITIONS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2004-06-17 | — | — | WO | claimed |
| WO-2004043435-A2 | SYSTEMIC DELIVERY OF ANTIVIRAL AGENTS | CONTROL DELIVERY SYSTEMS, INC. (US) | 2004-05-27 | — | — | WO | claimed |
| WO-2003092660-A1 | MONOCOMPARTMENT OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM | RANBAXY LABORATORIES LIMITED (US) | 2003-11-13 | — | — | WO | claimed |
| US-5540945-A | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1996-07-30 | — | — | US | claimed |
| US-5025004-A | Water-dispersible polymeric compositions | EASTMAN KODAK COMPANY (US) | 1991-06-18 | — | — | US | claimed |
| EP-0063014-B1 | A METHOD OF PREPARING COATED SOLID PREPARATIONS | SANKYO COMPANY LIMITED (JP) | 1985-08-14 | — | — | EP | claimed |
| US-4533562-A | Method of preparing coated solid preparations | SANKYO COMPANY, LIMITED (JP) | 1985-08-06 | — | — | US | claimed |
| EP-0063014-A2 | A method of preparing coated solid preparations | SANKYO COMPANY LIMITED (JP) | 1982-10-20 | — | — | EP | claimed |